Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,418 public trials 2,849 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

NCT06658834

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma

NCT06659276

Conditions: Behavior, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations: Policlinico S.Orsola Malpighi Bologna, Italy

View Trial Details

Recruiting

Molecular Mechanisms of Disease Relapse After Allogenic Stem Cell Transplantation in MDS Patients

NCT04587856

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy

Unità di Ricerca e di Malattie del sangue - Ematologia S. Luca Vecchio Florence, Italy

AOU San Martino-IST-Ematologia 1 Genova, Italy

Sezione di Ematologia - Ospedale S.Maria della Misericordia Perugia, Italy

View Trial Details

Recruiting

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

NCT05726110

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Tao Wang Taiyuan, Shanxi, China

View Trial Details

Recruiting

LMY-920 for Treatment of Relapsed or Refractory Myeloma

NCT05546723

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University Hospitals Seidman Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

NCT06183489

Conditions: Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Helsinki University Hospital Helsinki, Finland

CHD Vendée La Roche-sur-Yon, France

CHRU de Lille - Hopital Claude Huriez Lille, France

CHU Saint Eloi Département d'Hématologie Clinique Montpellier, France

View all 25 locations

View Trial Details

Recruiting

Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

NCT04859218

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Juravinski Hospital and Cancer Centre Hamilton, Ontario, Canada

View Trial Details

Recruiting

Comparison of Intralipid With SMOF Lipid Following HSCT

NCT06625372

Conditions: HSCT, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran Tehran, Iran

View Trial Details

Recruiting

EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia

NCT06642025

Conditions: Acute Myeloid Leukemia (AML), CAR-T, Hematologic Diseases, +6 more
Locations: The Second Affliated Hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Recruiting

A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma

NCT05299424

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Peking University Third Hospital Beijing, Beijing Municipality, China

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions